肿瘤学：临床前，临床yaboapp体育官网试验和市场后

Oncology has become the most research-intensive therapeutic area in drug development. You need a patient-centric CRO partner who can be wth you every step of the journey.

• 拥抱一个针对特定患者疗法的个性化药物方法，并在药物发育的临床前阶段开始yaboapp体育官网
  
• 利用生物标志物在临床肿瘤学发展中，为早期决策以及患者和网站选择提供关键数据
• 共同开发药物肿瘤学伴随诊断识别为了帮助识别最有可能从您的下一次癌症突破中受益的患者

该行业已接近免疫肿瘤学from many angles, thus requiring identification, development and refinement of models capable of recapitulating optimal biological dynamics along with the associated and relevant endpoints.

Making gains in临床试验的精密药物需要新颖的方法来快速测试和靶向合适的个体。除了几十个后期免疫肿瘤临床试验, we have also supported more than 70% of allFDA-approved companion diagnostic products.

药理Tumor Model Spotlights

临床患者招募

我们期待着在很多人与您见面肿瘤学和免疫学事件this year.